IPSC vs. MTA

Last updated Jun 23, 2026

IPSC (Century Therapeutics, Inc.) and MTA (Metalla Royalty & Streaming Ltd.) are both stocks. IPSC operates in Biotechnology (Healthcare), while MTA operates in Other Precious Metals & Mining (Basic Materials). Over the past 5 years, IPSC returned -38.21%/yr vs -4.84%/yr for MTA. At a 0.19 correlation, their price movements are largely independent.

Performance

IPSC vs. MTA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Century Therapeutics, Inc. (IPSC) and Metalla Royalty & Streaming Ltd. (MTA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IPSC achieves a 131.20% return, which is significantly higher than MTA's -6.81% return.

IPSC

• 1D: 0.44%
• 1M: 1.77%
• YTD: 131.20%
• 6M: 167.78%
• 1Y: 295.26%
• 3Y*: -12.22%
• 5Y*: -38.21%
• 10Y*: —

MTA

• 1D: -2.42%
• 1M: 6.77%
• YTD: -6.81%
• 6M: -13.79%
• 1Y: 110.14%
• 3Y*: 20.07%
• 5Y*: -4.84%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IPSC vs. MTA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
IPSC Century Therapeutics, Inc.	131.20%	-1.50%	-69.58%	-35.28%	-67.65%	-18.67%
MTA Metalla Royalty & Streaming Ltd.	-6.81%	209.96%	-18.51%	-36.95%	-29.15%	-31.72%

Correlation

The correlation between IPSC and MTA is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.24
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (5Y) Calculated over the trailing 5-year period	0.20
Correlation (All Time) Calculated using the full available price history since Jun 18, 2021	0.19

Fundamentals

Market Cap IPSC : $444.99M MTA : $693.62M
EPS IPSC : -$0.95 MTA : -$0.04
PB Ratio IPSC : 1.68 MTA : 2.73
Total Revenue (TTM) IPSC : $0.00 MTA : $14.70M
Gross Profit (TTM) IPSC : -$9.88M MTA : $12.51M
EBITDA (TTM) IPSC : -$103.02M MTA : $3.72M

Return for Risk

IPSC vs. MTA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IPSC

IPSC Risk / Return Rank: 94
IPSC Sharpe Ratio Rank: 95
IPSC Sortino Ratio Rank: 93
IPSC Omega Ratio Rank: 91
IPSC Calmar Ratio Rank: 96
IPSC Martin Ratio Rank: 93

MTA

MTA Risk / Return Rank: 85
MTA Sharpe Ratio Rank: 89
MTA Sortino Ratio Rank: 83
MTA Omega Ratio Rank: 83
MTA Calmar Ratio Rank: 86
MTA Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IPSC vs. MTA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Century Therapeutics, Inc. (IPSC) and Metalla Royalty & Streaming Ltd. (MTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IPSC	MTA	Difference
Sharpe ratio: Return per unit of total volatility	3.03	2.06	+0.97
Sortino ratio: Return per unit of downside risk	3.59	2.46	+1.13
Omega ratio: Gain probability vs. loss probability	1.44	1.32	+0.12
Calmar ratio: Return relative to maximum drawdown	8.04	3.35	+4.69
Martin ratio: Return relative to average drawdown	15.41	8.57	+6.84

IPSC vs. MTA - Sharpe Ratio Comparison

The current IPSC Sharpe Ratio is 3.03, which is higher than the MTA Sharpe Ratio of 2.06. The chart below compares the historical Sharpe Ratios of IPSC and MTA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

IPSC vs. MTA - Drawdown Comparison

The maximum IPSC drawdown since its inception was -98.78%, which is greater than MTA's maximum drawdown of -81.73%. Use the drawdown chart below to compare losses from any high point for IPSC and MTA.

Drawdown Indicators

	IPSC	MTA	Difference
Max Drawdown Largest peak-to-trough decline	-98.78%	-81.73%	-17.05%
Max Drawdown (1Y) Largest decline over 1 year	-36.98%	-33.04%	-3.94%
Max Drawdown (3Y) Largest decline over 3 years	-92.68%	-49.85%	-42.83%
Max Drawdown (5Y) Largest decline over 5 years	-98.78%	-73.63%	-25.15%
Current Drawdown Current decline from peak	-92.80%	-44.59%	-48.21%
Average Drawdown Average peak-to-trough decline	-80.54%	-41.39%	-39.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.27%	12.90%	+6.37%

Volatility

IPSC vs. MTA - Volatility Comparison

Century Therapeutics, Inc. (IPSC) and Metalla Royalty & Streaming Ltd. (MTA) have volatilities of 18.87% and 18.03%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IPSC	MTA	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.87%	18.03%	+0.84%
Volatility (6M) Calculated over the trailing 6-month period	80.94%	40.32%	+40.62%
Volatility (1Y) Calculated over the trailing 1-year period	98.51%	53.93%	+44.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	83.76%	53.56%	+30.20%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	84.14%	57.13%	+27.01%

Dividends

IPSC vs. MTA - Dividend Comparison

Neither IPSC nor MTA has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
IPSC Century Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
MTA Metalla Royalty & Streaming Ltd.	0.00%	0.00%	0.00%	0.75%	0.00%	0.00%	0.10%	0.75%	2.16%

Financials

Frequently Asked Questions

Can I hold both IPSC and MTA in my portfolio?

IPSC and MTA have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IPSC or MTA?

IPSC has higher volatility (18.87%) compared to MTA (18.03%). In terms of maximum drawdown, IPSC dropped -98.78% vs MTA's -81.73%.

Which has better risk-adjusted returns?

IPSC currently has the higher Sharpe Ratio (3.03 vs 2.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.